Additionally, changes in Alzheimer’s disease biomarkers, such as beta-amyloid (Aβ) deposition, tau phosphorylation, cortical thickness, or brain glucose metabolism, can occur 10–20 years before the clinical symptoms of AD appear (Vassilaki et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.